Cited by 192Advanced Drug Delivery SystemsAdvancements in Transdermal Drug DeliveryNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Open access

Pangeni, Rudra, Sharma, Shrestha, Mustafa, Gulam, Ali, Javed, Baboota, Sanjula·2014·Nanotechnology

Open this paper in CoChat — free account Open PDF

Abstract

Resveratrol, a potent natural antioxidant, possesses a wide range of pharmacological activities, but its oral bioavailability is very low due to its extensive hepatic and presystemic metabolism. The aim of the present study was to formulate a kinetically stable nanoemulsion (o/w) using vitamin E:sefsol (1:1) as the oil phase, Tween 80 as the surfactant and Transcutol P as the co-surfactant for the better management of Parkinson's disease. The nanoemulsion was prepared by a spontaneous emulsification method, followed by high-pressure homogenization. Ternary phase diagrams were constructed to locate the area of nanoemulsion. The prepared formulations were studied for globule size, zeta potential, refractive index, viscosity, surface morphology and in vitro and ex vivo release. The homogenized formulation, which contained 150 mg ml(-1) of resveratrol, showed spherical globules with an average globule diameter of 102 ± 1.46 nm, a least poly dispersity index of 0.158 ± 0.02 and optimal zeta potential values of -35 ± 0.02. The cumulative percentage drug release for the pre-homogenized resveratrol suspension, pre-homogenized nanoemulsion and post-homogenized nanoemulsion were 24.18 ± 2.30%, 54.32 ± 0.95% and 88.57 ± 1.92%, respectively, after 24 h. The ex vivo release also showed the cumulative percentage drug release of 85.48 ± 1.34% at 24 h. The antioxidant activity determined by using a DPPH assay showed high scavenging efficiency for the optimized formulation. Pharmacokinetic studies showed the higher concentration of the drug in the brain (brain/blood ratio: 2.86 ± 0.70) following intranasal administration of the optimized nanoemulsion. Histopathological studies showed decreased degenerative changes in the resveratrol nanoemulsion administered groups. The levels of GSH and SOD were significantly higher, and the level of MDA was significantly lower in the resveratrol nanoemulsion treated group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1088/0957-4484/25/48/485102

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
Sedlak, J., & Lindsay, R. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90092-4 · Cited by 8,092
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,893
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,409
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 487
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Effect of sulfhydryl reagents on peroxidation in microsomes
Utley, H. G., Bernheim, F., & Hochstein, P. E. (1967) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(67)90273-1 · Cited by 446
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F. J., Wu, Q., Lu, Y., Gong, Q., & Shi, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384

Show all 32 references

Research works printed but not linked: 2

Ahmad M P, 2012, J. Clin. Diagn. Res., 6, 542
Shadab M, 2014, Expert Opin. Drug Deliv., 11, 1

Sorted by citations

Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 306
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Molecular mechanisms of anticancer effect of rutin
Imani, A., Maleki, N., Bohlouli, S., Kouhsoltani, M., Sharifi, S., & Dizaj, S. M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6977 · Cited by 245
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents
Angelova, A., Garamus, V. M., Angelov, B., Tian, Z., Li, Y., & Zou, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.006 · Cited by 211
Nanodelivery of Natural Antioxidants: An Anti-aging Perspective
Vaiserman, A. M., Koliada, A. K., Zayachkivska, A., & Lushchak, O. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00447 · Cited by 215
Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson’s Disease Model
Gaba, B., Khan, T. M., Haider, M. F., Alam, T., Baboota, S., Parvez, S., & Ali, J. (2019) · BioMed Research International · doi:10.1155/2019/2382563 · Cited by 183
Self-citation
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 187
Polyphenols in Metabolic Diseases
Gasmi, A., Mujawdiya, P. K., Noor, S., Lysiuk, R., Darmohray, R., Piscopo, S., Lenchyk, L. V., Antonyak, H., Dehtiarova, K., Shanaida, M., et al. (2022) · Molecules · doi:10.3390/molecules27196280 · Cited by 187
Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 178
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases
Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.01.005 · Cited by 133
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124
Curcumin- and Fish Oil-Loaded Spongosome and Cubosome Nanoparticles with Neuroprotective Potential against H2O2-Induced Oxidative Stress in Differentiated Human SH-SY5Y Cells
Rakotoarisoa, M., Angelov, B., Garamus, V. M., & Angelova, A. (2019) · ACS Omega · doi:10.1021/acsomega.8b03101 · Cited by 125
Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity
Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Collado-González, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.030 · Cited by 121
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models
Ganesan, P., Ko, H.-M., Kim, I., & Choi, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93918 · Cited by 119
Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases
Dai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 128
Design Expert ® supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson’s disease
Kumar, S., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/43/435101 · Cited by 115
Self-citation
Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson’s Disease: Current Knowledge and Future Perspectives
Balakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I., & Choi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6680935 · Cited by 117
Recent progress in nanocarriers for direct nose to brain drug delivery
Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 114
Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs
Pires, P. C., Rodrigues, M., Alves, G., & Santos, A. O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030588 · Cited by 105
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
Karami, Z., Zanjani, M. R. S., & Hamidi, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.021 · Cited by 102
Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: Formulation, behavioural and biochemical estimation
Pandey, Y. R., Kumar, S., Gupta, B. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/2/025102 · Cited by 96
Self-citation
Personalized nanomedicine for CNS diseases
Kaushik, A., Jayant, R. D., Bhardwaj, V., & Nair, M. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.010 · Cited by 95
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles
Trotta, V., Pavan, B., Ferraro, L., Beggiato, S., Traini, D., dos Reis, L. G., Scalia, S., & Dalpiaz, A. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.010 · Cited by 86
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease
Mittal, P., Dhankhar, S., Chauhan, S., Garg, N., Bhattacharya, T., Ali, M., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M. M., Ahmad, W., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070908 · Cited by 93
Coconut oil-based resveratrol nanoemulsion: Optimization using response surface methodology, stability assessment and pharmacokinetic evaluation
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., & Md, S. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.129721 · Cited by 87
In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival
Guerzoni, L. P. B., Nicolas, V., & Angelova, A. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2080-4 · Cited by 81
Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases
Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 83
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments
Zamanian, M. Y., Romero‐Parra, R. M., Soltani, A., Kujawska, M., Mustafa, Y. F., Raheem, G., Al-Awsi, L., Lafta, H. A., Taheri, N., Heidari, M., et al. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08409-1 · Cited by 78
Role of nanostructures in improvising oral medicine
Ghosh, S., Ghosh, S., & Sil, P. C. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.04.004 · Cited by 78
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Khatri, D. K., Preeti, K., Tonape, S., Bhattacharjee, S., Patel, M., Shah, S., Singh, P. K., Srivastava, S., Gugulothu, D., Vora, L., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x20666220507022701 · Cited by 75
Resveratrol-loaded nanoemulsion gel system to ameliorate UV-induced oxidative skin damage: from in vitro to in vivo investigation of antioxidant activity enhancement
Sharma, B., Iqbal, B., Kumar, S., Ali, J., & Baboota, S. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01964-3 · Cited by 74
Self-citation
Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy
Kuo, Y., Wang, I.-H., & Rajesh, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.015 · Cited by 74
Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability
Nagi, A., Iqbal, B., Kumar, S., Sharma, S., Ali, J., & Baboota, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.05.019 · Cited by 74
Self-citation
Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease
Kumar, S., Dang, S., Nigam, K., Ali, J., & Baboota, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.2035 · Cited by 70
Self-citation
Silymarin-Loaded Nanostructured Lipid Carrier Gel for The Treatment of Skin Cancer
Iqbal, B., Ali, J., Ganguli, M., Mishra, S., & Baboota, S. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0235 · Cited by 70
Self-citation
Intranasal delivery of paeoniflorin nanocrystals for brain targeting
Wu, C., Li, B., Zhang, Y., Chen, T., Chen, C., Jiang, W., Wang, Q., & Chen, T. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.11.002 · Cited by 69
Role of Rutin Nanoemulsion in Ameliorating Oxidative Stress: Pharmacokinetic and Pharmacodynamics Studies
Sharma, S., Rabbani, S. A., Narang, J. K., Pottoo, F. H., Ali, J., Kumar, S., & Baboota, S. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104890 · Cited by 69
Self-citation
Pep‐Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self‐Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP‐DHA
Angelova, A., Drechsler, M., Garamus, V. M., & Angelov, B. (2019) · ChemNanoMat · doi:10.1002/cnma.201900468 · Cited by 68
Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer
Hasan, N., Imran, M., Sheikh, A., Tiwari, N., Jaimini, A., Kesharwani, P., Jain, G. K., & Ahmad, F. J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116454 · Cited by 67
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach
Kuk, D.-H., Ha, E., Ha, D.-H., Sim, W., Lee, S.-K., Jeong, J.-S., Kim, J. S., Baek, I., Park, H., Choi, D. H., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120688 · Cited by 65
Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice
Pangeni, R., Kang, S.-W., Oak, M., Park, E., & Park, J. W. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.059 · Cited by 66
Self-citation
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Saha, P., Kathuria, H., & Pandey, M. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.021 · Cited by 67
Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats
Wahba, M. G. F., Messiha, B. A. S., & Abo‐Saif, A. A. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1125931 · Cited by 64
Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study
Shah, P., Dubey, P., Vyas, B., Kaul, A., Mishra, A. K., Chopra, D., & Patel, P. V. (2021) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2021.1939709 · Cited by 65
Therapeutic applications of resveratrol nanoformulations
Arora, D., & Jaglan, S. (2017) · Environmental Chemistry Letters · doi:10.1007/s10311-017-0660-0 · Cited by 60
N,N,N‑trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery
Pardeshi, C. V., & Belgamwar, V. S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.032 · Cited by 60
Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson’s disease model
Sharma, S., Narang, J. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/37/375101 · Cited by 59
Self-citation
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol
Ashrafizadeh, M., Javanmardi, S., Moradi-Ozarlou, M., Mohammadinejad, R., Farkhondeh, T., Samarghandian, S., & Garg, M. (2020) · Bioscience Reports · doi:10.1042/bsr20200257 · Cited by 58
Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide
Bayanati, M., Khosroshahi, A. G., Alvandi, M., & Mahboobian, M. M. (2021) · Journal of Nanomaterials · doi:10.1155/2021/1546798 · Cited by 57
CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect
Ashhar, M. U., Kumar, S., Ali, J., & Baboota, S. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105035 · Cited by 55
Self-citation
Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease
Wang, J., Yang, D., Yu, Y., Shao, G., & Wang, Q. (2016) · Nutrients · doi:10.3390/nu8030142 · Cited by 51
Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration
Martano, S., Matteis, V. D., Cascione, M., & Rinaldi, R. (2022) · Nanomaterials · doi:10.3390/nano12142337 · Cited by 54
Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Pérez-Araluce, M., Jüngst, T., Sanmartín, C., Prósper, F., Plano, D., & Mazo, M. M. (2024) · Biomimetics · doi:10.3390/biomimetics9010023 · Cited by 52
Application of Nanodiagnostics and Nanotherapy to CNS Diseases
Zhang, W., Wang, W., Yu, D. X., Xiao, Z., & He, Z. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0163 · Cited by 51
Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases
Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48
Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect
Pangeni, R., Choi, J. U., Panthi, V. K., Byun, Y., & Park, J. W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s167958 · Cited by 48
Self-citation
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions
Tripathi, R. S., Gupta, R. V., Sahu, M., Srivastava, D., Das, A., Ambasta, R. K., & Kumar, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16693-2 · Cited by 54
The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems
Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 47
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
Mistretta, M., Farini, A., Torrente, Y., & Villa, C. (2023) · Brain · doi:10.1093/brain/awad014 · Cited by 45
Structure and dynamics of cetyltrimethylammonium chloride-sodium dodecylsulfate (CTAC-SDS) catanionic vesicles: High-value nano-vehicles from low-cost surfactants
Krauss, I. R., Imperatore, R., Santis, A. D., Luchini, A., Paduano, L., & D’Errico, G. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.04.032 · Cited by 44
Attenuation of Oxidative Damage by Coenzyme Q 10 Loaded Nanoemulsion Through Oral Route for the Management of Parkinson's Disease
Gupta, B. K., Kumar, S., Kaur, H., Ali, J., & Baboota, S. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1959 · Cited by 44
Self-citation
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
Bonferoni, M. C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., & Giunchedi, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121246 · Cited by 44
Nanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 44
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 43
Sirtuins as modifiers of Parkinson's disease pathology
Tang, B. L. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23806 · Cited by 41
Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats
Locatelli, F. M., Kawano, T., Iwata, H., Aoyama, B., Eguchi, S., Nishigaki, A., Yamanaka, D., Tateiwa, H., Shigematsu-Locatelli, M., & Yokoyama, M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.08.006 · Cited by 40
Nanoemulsion in drug delivery
Patel, M. R., Patel, R. B., & Thakore, S. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00030-3 · Cited by 39
A comprehensive review of nano drug delivery system in the treatment of CNS disorders
Spandana, K. M. A., Bhaskaran, M., Karri, V. V. S. N. R., & Natarajan, J. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101628 · Cited by 41
Emerging Trends in the Delivery of Resveratrol by Nanostructures: Applications of Nanotechnology in Life Sciences
Chopra, H., Bibi, S., Islam, F., Ahmad, S. U., Olawale, O. A., Alhumaydhi, F. A., Marzouki, R., Baig, A. A., & Emran, T. B. (2022) · Journal of Nanomaterials · doi:10.1155/2022/3083728 · Cited by 42
Lipid nanocarrier of selegiline augmented anti-Parkinson’s effect via P-gp modulation using quercetin
Qamar, Z., Ashhar, M. U., Annu, Qizilbash, F. F., Sahoo, P. K., Ali, A., Ali, J., & Baboota, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121131 · Cited by 38
Self-citation
Protective effect of ursodeoxycholic acid, resveratrol, and N -acetylcysteine on nonalcoholic fatty liver disease in rats
Ali, M. H. H., Messiha, B. A. S., & Abdellatif, H. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1060247 · Cited by 38
Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?
Rehman, S., Nabi, B., Zafar, A., Baboota, S., & Ali, J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1684895 · Cited by 37
Self-citation
Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers
Waqar, M. A., Zaman, M., Hameed, H., Jamshaid, M., Irfan, A., Shazly, G. A., Paiva‐Santos, A. C., & Jardan, Y. A. B. (2023) · ACS Omega · doi:10.1021/acsomega.3c04444 · Cited by 34
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease
Ashhar, M. U., Vyas, P., Vohora, D., Sahoo, P. K., Nigam, K., Dang, S., Ali, J., & Baboota, S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121683 · Cited by 36
Self-citation
In Vitro–In Silico Modeling Approach to Rationally Designed Simple and Versatile Drug Delivery Systems
Bouzo, B. L., Calvelo, M., Martín‐Pastor, M., García‐Fandiño, R., & de la Fuente, M. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c02731 · Cited by 35
Grape By-Products in Sustainable Cosmetics: Nanoencapsulation and Market Trends
Castro, M. L., Ferreira, J. P., Pintado, M., Ramos, O. L., Borges, S., & Baptista-Silva, S. (2023) · Applied Sciences · doi:10.3390/app13169168 · Cited by 32
Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism
Allen, E. N., Potdar, S., Tapias, V., Parmar, M. S., Mizuno, C. S., Rimando, A. M., & Cavanaugh, J. E. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.015 · Cited by 32
Nanoemulsions-Based Drug Delivery for Brain Tumors
Ding, Z., Jiang, Y., & Liu, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00012-9 · Cited by 31
Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition
Gorain, B., Rajeswary, D. C., Pandey, M., Kesharwani, P., Kumbhar, S. A., & Choudhury, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200313125613 · Cited by 31
Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization, in vitro and in vivo evaluation
Ahmed, B., Rizwanullah, M., Mir, S. R., Akhtar, M. S., & Amin, S. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac9267 · Cited by 32
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors
Nevins, S., McLoughlin, C. D., Oliveros, A., Stein, J. B., Rashid, M. A., Hou, Y., Jang, M., & Lee, K. (2023) · Small · doi:10.1002/smll.202300744 · Cited by 31
Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Bicker, J., Fortuna, A. C., Alves, G., & Falcão, A. C. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115101544 · Cited by 30
Potential applications of nanomedicine for treating Parkinson's disease
Shankar, J., Geetha, K. M., & Wilson, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102793 · Cited by 29
Development and Characterization of Resveratrol Nanoemulsions Carrying Dual-Imaging Agents
Herneisey, M., Williams, J. M., Mirtič, J., Liu, L., Potdar, S., Bagia, C., Cavanaugh, J. E., & Janjic, J. M. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0050 · Cited by 28
Effects of N-butylphthalide on the activation of Keap1/Nrf-2 signal pathway in rats after carbon monoxide poisoning
Li, Q., Cheng, Y., Bi, M., Lin, H., Chen, Y., Zou, Y., Liu, Y., Kang, H., & Guo, Y. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.05.009 · Cited by 27
Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
Burns, J., Buck, A. C., Souza, S. D., Dube, A., & Bardien, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c04862 · Cited by 26
Lipid-based nanoparticles for drug delivery in Parkinson’s disease
Cai, H., Liu, D., Xue, W.-W., Ma, L., Xie, H.-T., & Ning, K. (2024) · Translational Neuroscience · doi:10.1515/tnsci-2022-0359 · Cited by 26
Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats
Mohammad, Khan, U. A., Warsi, M. H., Alkreathy, H. M., Karim, S., Jain, G. K., & Ali, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1188470 · Cited by 27
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
Zhang, X., Wang, M., Liu, Z., Wang, Y., Chen, L., Guo, J., Zhang, W., Zhang, Y., Yu, C., Bie, T., et al. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1247162 · Cited by 23
Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A
Sa, F., Guo, B. J., Li, S., Zhang, Z. J., Chan, H. M., Zheng, Y., & Lee, S. M. (2015) · Parkinson s Disease · doi:10.1155/2015/951361 · Cited by 25
A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics
Singh, A., Ahmad, I., Ahmad, S., Iqbal, Z., & Ahmad, F. J. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1151032 · Cited by 23
Resveratrol Attenuates Aβ-Induced Early Hippocampal Neuron Excitability Impairment via Recovery of Function of Potassium Channels
Yin, H., Wang, H., Zhang, H., Gao, N., Zhang, T., & Yang, Z. R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9726-9 · Cited by 23
Delivery nanosystems based on sterically hindered phenol derivatives containing a quaternary ammonium moiety: Synthesis, cholinesterase inhibition and antioxidant activity
Pashirova, T. N., Burilova, E. A., Tagasheva, R. G., Zueva, I. V., Гибадуллина, Э. М., Nizameev, I. R., Sudakov, I. A., Vyshtakalyuk, A. B., Voloshina, A. D., Kadirov, M. K., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108753 · Cited by 21
Enhancement in brain uptake of vitamin D3 nanoemulsion for treatment of cerebral ischemia: formulation, gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models
Kumar, M., Nishad, D. K., Kumar, A., Bhatnagar, A., Karwasra, R., Khanna, K., Keerthana, S. V., Sharma, D., Dua, K., Mudaliar, V., et al. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1801870 · Cited by 21
Designing nanoformulation for the nose‐to‐brain delivery in Parkinson's disease: Advancements and barrier
Kiran, P., Debnath, S. K., Neekhra, S., Pawar, V. S., Khan, A., Dias, F., Pallod, S., & Srivastava, R. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1768 · Cited by 26
Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances
Samie, S. M. A., & Nasr, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821222-6.00011-7 · Cited by 21
Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 21

Authors: Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S.
Affiliations: Jamia Hamdard (IN)
Corresponding author: Baboota, Sanjula
ORCID: Pangeni, Rudra
Sharma, Shrestha
Mustafa, Gulam
Ali, Javed
Baboota, Sanjula
Venue: Nanotechnology
Publisher: IOP Publishing
Published: 2014-11-13
Volume: 25
Issue: 48
Pages: 485102
ISSN: 0957-4484 (ISSN-L)
1361-6528
DOI: 10.1088/0957-4484/25/48/485102
OpenAlex: W1967033368
Cited by: 192
References: 32
Citations by year: 2026: 5 · 2025: 18 · 2024: 23 · 2023: 24 · 2022: 22 · 2021: 18 · 2020: 23 · 2019: 18 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 8
FWCI: 5.85
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: iopscience.iop.org/info/page/text-and-data-mining (tdm)
iopscience.iop.org/page/copyright (vor)
Locations: Nanotechnology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: resveratrol, nanoemulsions, Parkinson's disease, vitamin E, brain targeting, intranasal drug delivery, oxidative stress, antioxidant activity, high-pressure homogenization, drug bioavailability, pharmacokinetics, lipid peroxidation, glutathione, superoxide dismutase, malondialdehyde, neuroprotection
MeSH terms: Resveratrol, Animals, Antioxidants, Biological Availability, Brain, Chemistry, Pharmaceutical, Emulsions, Female, Male, Parkinson Disease, Particle Size, Polysorbates, Solubility, Stilbenes, Swine, Viscosity, Vitamin E, Rats, Wistar, Oxidative Stress, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks